Related Experiment Video

Updated: Jun 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma

Shanrong Shu1, Xiaomao Li, Yuebo Yang

  • 1Department of Obstetrics and Gynecology, The Third Affiliated Hospital, Sun Yat-sen University, 600 TianHe Road, 510630 Guangzhou, People's Republic of China.

International Immunopharmacology
|December 15, 2010
PubMed

Insights

Targeting the type-1 insulin-like growth factor receptor (IGF-1R) with RNA interference in endometrial carcinoma induces apoptosis and reduces tumor growth. This highlights IGF-1R as a promising therapeutic target for endometrial cancer.

Area of Science:

  • Molecular oncology
  • Cancer therapeutics
  • Gene silencing

Background:

  • The type-1 insulin-like growth factor receptor (IGF-1R) is a tyrosine protein kinase receptor implicated in tumor initiation and progression.
  • Overactivation of IGF-1R is frequently observed in various human malignancies, including endometrial carcinoma.
  • IGF-1R signaling pathways play a critical role in cell proliferation, survival, and tumorigenesis.

Purpose of the Study:

  • To evaluate the therapeutic potential of targeting IGF-1R in endometrial carcinoma.
  • To investigate the effects of down-regulating IGF-1R expression on apoptosis and tumorigenicity in endometrial cancer models.

Main Methods:

  • RNA interference (RNAi) technology was employed to specifically down-regulate IGF-1R expression in endometrial carcinoma cells.
  • Apoptosis induction, downstream protein phosphorylation, and in vivo tumorigenicity were analyzed post-IGF-1R knockdown.
  • Tumor tissue proliferation index was assessed to evaluate the impact on tumor growth.

Main Results:

  • RNAi-mediated down-regulation of IGF-1R significantly induced apoptosis in endometrial carcinoma.
  • Reduced downstream protein phosphorylation was observed, indicating inhibition of key signaling pathways.
  • In vivo studies demonstrated decreased tumorigenicity and a lower proliferation index in tumor tissues.

Conclusions:

  • Targeting IGF-1R with RNA interference shows significant therapeutic potential for endometrial carcinoma.
  • IGF-1R represents a viable therapeutic target for human endometrial carcinoma, offering a novel treatment strategy.
  • The findings support further development of RNAi-based therapies for endometrial cancer targeting the IGF-1R pathway.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...